Endogenous hormones and coronary heart disease in postmenopausal women

Yu Chen, Anne Zeleniuch-Jacquotte, Alan A. Arslan, Oktawia Wojcik, Paolo Toniolo, Roy E. Shore, Mortimer Levitz, Karen L. Koenig

Research output: Contribution to journalArticle

Abstract

The association between serum levels of endogenous estrogens in postmenopausal women and the subsequent risk of coronary heart disease (CHD) was examined in a prospective case-control study nested within the New York University Women's Health Study (NYUWHS). The NYUWHS is a prospective cohort study of 14,274 healthy women enrolled between 1985 and 1991. A total of 99 women who were postmenopausal and free of cardiovascular disease at enrollment and who subsequently experienced CHD, defined as non-fatal myocardial infarction (MI), fatal CHD, percutaneous transluminal coronary angioplasty (PTCA), or coronary artery bypass grafting (CABG), were matched 1:2 by baseline age, blood sampling date, and postmenopausal status to controls who remained free of CHD as of the date of diagnosis of the matching case. Biochemical analyses for total estradiol, estrone, percent free estradiol, percent estradiol bound to sex hormone-binding globulin (SHBG), and SHBG were performed on pre-diagnostic stored serum samples. Participants had not used any hormone medications in the 6 months prior to blood collection. In the model adjusting only for matching factors, the risk of CHD in the top tertile of calculated bioavailable estradiol was elevated compared with the bottom tertile (OR = 2.10; 95% CI = 1.13-3.90, P for trend = 0.03), and the risk in the top tertile of SHBG was reduced (OR = 0.50, 95% CI = 0.28-0.92, P for trend < 0.01). However, these associations disappeared after adjusting for baseline hypertension status, body mass index, and serum cholesterol levels. These findings suggest that circulating estradiol and SHBG are not associated with CHD risk in postmenopausal women beyond what can be explained by the variation in hypertension status, BMI, and cholesterol.

Original languageEnglish (US)
Pages (from-to)414-419
Number of pages6
JournalAtherosclerosis
Volume216
Issue number2
DOIs
StatePublished - Jun 2011

Fingerprint

Coronary Disease
Sex Hormone-Binding Globulin
Hormones
Estradiol
Women's Health
Serum
Cholesterol
Hypertension
Coronary Balloon Angioplasty
Estrone
Coronary Artery Bypass
Case-Control Studies
Estrogens
Body Mass Index
Cohort Studies
Cardiovascular Diseases
Myocardial Infarction
Prospective Studies

Keywords

  • Coronary heart disease
  • Epidemiology
  • Hormones
  • Nested case-control studies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Chen, Y., Zeleniuch-Jacquotte, A., Arslan, A. A., Wojcik, O., Toniolo, P., Shore, R. E., ... Koenig, K. L. (2011). Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis, 216(2), 414-419. https://doi.org/10.1016/j.atherosclerosis.2011.01.053

Endogenous hormones and coronary heart disease in postmenopausal women. / Chen, Yu; Zeleniuch-Jacquotte, Anne; Arslan, Alan A.; Wojcik, Oktawia; Toniolo, Paolo; Shore, Roy E.; Levitz, Mortimer; Koenig, Karen L.

In: Atherosclerosis, Vol. 216, No. 2, 06.2011, p. 414-419.

Research output: Contribution to journalArticle

Chen, Y, Zeleniuch-Jacquotte, A, Arslan, AA, Wojcik, O, Toniolo, P, Shore, RE, Levitz, M & Koenig, KL 2011, 'Endogenous hormones and coronary heart disease in postmenopausal women', Atherosclerosis, vol. 216, no. 2, pp. 414-419. https://doi.org/10.1016/j.atherosclerosis.2011.01.053
Chen Y, Zeleniuch-Jacquotte A, Arslan AA, Wojcik O, Toniolo P, Shore RE et al. Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis. 2011 Jun;216(2):414-419. https://doi.org/10.1016/j.atherosclerosis.2011.01.053
Chen, Yu ; Zeleniuch-Jacquotte, Anne ; Arslan, Alan A. ; Wojcik, Oktawia ; Toniolo, Paolo ; Shore, Roy E. ; Levitz, Mortimer ; Koenig, Karen L. / Endogenous hormones and coronary heart disease in postmenopausal women. In: Atherosclerosis. 2011 ; Vol. 216, No. 2. pp. 414-419.
@article{a8be57066edf4b149998bbf925531759,
title = "Endogenous hormones and coronary heart disease in postmenopausal women",
abstract = "The association between serum levels of endogenous estrogens in postmenopausal women and the subsequent risk of coronary heart disease (CHD) was examined in a prospective case-control study nested within the New York University Women's Health Study (NYUWHS). The NYUWHS is a prospective cohort study of 14,274 healthy women enrolled between 1985 and 1991. A total of 99 women who were postmenopausal and free of cardiovascular disease at enrollment and who subsequently experienced CHD, defined as non-fatal myocardial infarction (MI), fatal CHD, percutaneous transluminal coronary angioplasty (PTCA), or coronary artery bypass grafting (CABG), were matched 1:2 by baseline age, blood sampling date, and postmenopausal status to controls who remained free of CHD as of the date of diagnosis of the matching case. Biochemical analyses for total estradiol, estrone, percent free estradiol, percent estradiol bound to sex hormone-binding globulin (SHBG), and SHBG were performed on pre-diagnostic stored serum samples. Participants had not used any hormone medications in the 6 months prior to blood collection. In the model adjusting only for matching factors, the risk of CHD in the top tertile of calculated bioavailable estradiol was elevated compared with the bottom tertile (OR = 2.10; 95{\%} CI = 1.13-3.90, P for trend = 0.03), and the risk in the top tertile of SHBG was reduced (OR = 0.50, 95{\%} CI = 0.28-0.92, P for trend < 0.01). However, these associations disappeared after adjusting for baseline hypertension status, body mass index, and serum cholesterol levels. These findings suggest that circulating estradiol and SHBG are not associated with CHD risk in postmenopausal women beyond what can be explained by the variation in hypertension status, BMI, and cholesterol.",
keywords = "Coronary heart disease, Epidemiology, Hormones, Nested case-control studies",
author = "Yu Chen and Anne Zeleniuch-Jacquotte and Arslan, {Alan A.} and Oktawia Wojcik and Paolo Toniolo and Shore, {Roy E.} and Mortimer Levitz and Koenig, {Karen L.}",
year = "2011",
month = "6",
doi = "10.1016/j.atherosclerosis.2011.01.053",
language = "English (US)",
volume = "216",
pages = "414--419",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Endogenous hormones and coronary heart disease in postmenopausal women

AU - Chen, Yu

AU - Zeleniuch-Jacquotte, Anne

AU - Arslan, Alan A.

AU - Wojcik, Oktawia

AU - Toniolo, Paolo

AU - Shore, Roy E.

AU - Levitz, Mortimer

AU - Koenig, Karen L.

PY - 2011/6

Y1 - 2011/6

N2 - The association between serum levels of endogenous estrogens in postmenopausal women and the subsequent risk of coronary heart disease (CHD) was examined in a prospective case-control study nested within the New York University Women's Health Study (NYUWHS). The NYUWHS is a prospective cohort study of 14,274 healthy women enrolled between 1985 and 1991. A total of 99 women who were postmenopausal and free of cardiovascular disease at enrollment and who subsequently experienced CHD, defined as non-fatal myocardial infarction (MI), fatal CHD, percutaneous transluminal coronary angioplasty (PTCA), or coronary artery bypass grafting (CABG), were matched 1:2 by baseline age, blood sampling date, and postmenopausal status to controls who remained free of CHD as of the date of diagnosis of the matching case. Biochemical analyses for total estradiol, estrone, percent free estradiol, percent estradiol bound to sex hormone-binding globulin (SHBG), and SHBG were performed on pre-diagnostic stored serum samples. Participants had not used any hormone medications in the 6 months prior to blood collection. In the model adjusting only for matching factors, the risk of CHD in the top tertile of calculated bioavailable estradiol was elevated compared with the bottom tertile (OR = 2.10; 95% CI = 1.13-3.90, P for trend = 0.03), and the risk in the top tertile of SHBG was reduced (OR = 0.50, 95% CI = 0.28-0.92, P for trend < 0.01). However, these associations disappeared after adjusting for baseline hypertension status, body mass index, and serum cholesterol levels. These findings suggest that circulating estradiol and SHBG are not associated with CHD risk in postmenopausal women beyond what can be explained by the variation in hypertension status, BMI, and cholesterol.

AB - The association between serum levels of endogenous estrogens in postmenopausal women and the subsequent risk of coronary heart disease (CHD) was examined in a prospective case-control study nested within the New York University Women's Health Study (NYUWHS). The NYUWHS is a prospective cohort study of 14,274 healthy women enrolled between 1985 and 1991. A total of 99 women who were postmenopausal and free of cardiovascular disease at enrollment and who subsequently experienced CHD, defined as non-fatal myocardial infarction (MI), fatal CHD, percutaneous transluminal coronary angioplasty (PTCA), or coronary artery bypass grafting (CABG), were matched 1:2 by baseline age, blood sampling date, and postmenopausal status to controls who remained free of CHD as of the date of diagnosis of the matching case. Biochemical analyses for total estradiol, estrone, percent free estradiol, percent estradiol bound to sex hormone-binding globulin (SHBG), and SHBG were performed on pre-diagnostic stored serum samples. Participants had not used any hormone medications in the 6 months prior to blood collection. In the model adjusting only for matching factors, the risk of CHD in the top tertile of calculated bioavailable estradiol was elevated compared with the bottom tertile (OR = 2.10; 95% CI = 1.13-3.90, P for trend = 0.03), and the risk in the top tertile of SHBG was reduced (OR = 0.50, 95% CI = 0.28-0.92, P for trend < 0.01). However, these associations disappeared after adjusting for baseline hypertension status, body mass index, and serum cholesterol levels. These findings suggest that circulating estradiol and SHBG are not associated with CHD risk in postmenopausal women beyond what can be explained by the variation in hypertension status, BMI, and cholesterol.

KW - Coronary heart disease

KW - Epidemiology

KW - Hormones

KW - Nested case-control studies

UR - http://www.scopus.com/inward/record.url?scp=79957980735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957980735&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2011.01.053

DO - 10.1016/j.atherosclerosis.2011.01.053

M3 - Article

C2 - 21367421

AN - SCOPUS:79957980735

VL - 216

SP - 414

EP - 419

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -